Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Pain 1Neoplasms 1Constipation 1Cancer Pain 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
oxycodone naloxone combination × Clear all
NCT02293785 2016-03-21

GREAT - Good Response With Appropriate Treatment

Mario Negri Institute for Pharmacological Research

Completed
200 enrolled

Cancer Pain, Neoplasms

NCT01014559 2015-09-28

OXN3505

Mundipharma SAS

Phase 3 Terminated
225 enrolled
Other

Constipation, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡